EP1.12-06 New Treatment Option for ES-SCLC: Patient Characteristics and Use of an Atezolizumab Regimen in the Real-World Setting

S. Mccune; T. Ton; S. Whipple; R. Induru; L. Horn; I. Percent; T. Mekhail; J. Goldschmidt; T. Leal; G. Macvicar; F. Braiteh; D. Daniel; M. Hussein; A. Mansfield; S. Lam; A. Johnson; S. Morris; A. Spira

doi:10.1016/J.JTHO.2019.08.2251

EP1.12-06 New Treatment Option for ES-SCLC: Patient Characteristics and Use of an Atezolizumab Regimen in the Real-World Setting

S. Mccune
, T. Ton
, S. Whipple
, R. Induru
, L. Horn
, I. Percent
, T. Mekhail
, J. Goldschmidt
, T. Leal
, G. Macvicar
, F. Braiteh
, D. Daniel
, M. Hussein
, A. Mansfield
, S. Lam
, A. Johnson
, S. Morris
, A. Spira

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of Thoracic Oncology
Volume	14
Issue number	10
DOIs	https://doi.org/10.1016/J.JTHO.2019.08.2251
State	Published - Oct 1 2019

Disciplines

Medicine and Health Sciences
Critical Care

Access to Document

10.1016/J.JTHO.2019.08.2251License: Unspecified

Cite this

Mccune, S., Ton, T., Whipple, S., Induru, R., Horn, L., Percent, I., Mekhail, T., Goldschmidt, J., Leal, T., Macvicar, G., Braiteh, F., Daniel, D., Hussein, M., Mansfield, A., Lam, S., Johnson, A., Morris, S., & Spira, A. (2019). EP1.12-06 New Treatment Option for ES-SCLC: Patient Characteristics and Use of an Atezolizumab Regimen in the Real-World Setting. Journal of Thoracic Oncology, 14(10). https://doi.org/10.1016/J.JTHO.2019.08.2251

Mccune, S, Ton, T, Whipple, S, Induru, R, Horn, L, Percent, I, Mekhail, T, Goldschmidt, J, Leal, T, Macvicar, G, Braiteh, F, Daniel, D, Hussein, M, Mansfield, A, Lam, S, Johnson, A, Morris, S & Spira, A 2019, 'EP1.12-06 New Treatment Option for ES-SCLC: Patient Characteristics and Use of an Atezolizumab Regimen in the Real-World Setting', Journal of Thoracic Oncology, vol. 14, no. 10. https://doi.org/10.1016/J.JTHO.2019.08.2251

@article{7573fa08c558472ea83873c20dfda206,

title = "EP1.12-06 New Treatment Option for ES-SCLC: Patient Characteristics and Use of an Atezolizumab Regimen in the Real-World Setting",

author = "S. Mccune and T. Ton and S. Whipple and R. Induru and L. Horn and I. Percent and T. Mekhail and J. Goldschmidt and T. Leal and G. Macvicar and F. Braiteh and D. Daniel and M. Hussein and A. Mansfield and S. Lam and A. Johnson and S. Morris and A. Spira",

year = "2019",

month = oct,

day = "1",

doi = "10.1016/J.JTHO.2019.08.2251",

language = "American English",

volume = "14",

journal = "Journal of Thoracic Oncology",

number = "10",

}

TY - JOUR

T1 - EP1.12-06 New Treatment Option for ES-SCLC: Patient Characteristics and Use of an Atezolizumab Regimen in the Real-World Setting

AU - Mccune, S.

AU - Ton, T.

AU - Whipple, S.

AU - Induru, R.

AU - Horn, L.

AU - Percent, I.

AU - Mekhail, T.

AU - Goldschmidt, J.

AU - Leal, T.

AU - Macvicar, G.

AU - Braiteh, F.

AU - Daniel, D.

AU - Hussein, M.

AU - Mansfield, A.

AU - Lam, S.

AU - Johnson, A.

AU - Morris, S.

AU - Spira, A.

PY - 2019/10/1

Y1 - 2019/10/1

UR - https://api.elsevier.com/content/article/PII:S155608641932934X?httpAccept=text/xml

U2 - 10.1016/J.JTHO.2019.08.2251

DO - 10.1016/J.JTHO.2019.08.2251

M3 - Article

VL - 14

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 10

ER -

EP1.12-06 New Treatment Option for ES-SCLC: Patient Characteristics and Use of an Atezolizumab Regimen in the Real-World Setting

Disciplines

Access to Document

Other files and links

Cite this